PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells

Overview of attention for article published in OncoTargets and therapy, November 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPIES COMPRISING SHP2 INHIBITORS AND EGFR TYROSINE KINASE INHIBITORS

Application WO-2022235815-A1

World Intellectual Property Organisation (WIPO)